22nd Sep 2023

Vaccine-waiver row refuses to die at EU-AU summit

  • While more than 70 percent of Europeans are fully-vaccinated, the figure for Africans is just 11 percent (Photo: UNICEF Ethiopia)
Listen to article

African Union countries will seek backing to lift patent protections on Covid-19 vaccines this week but there are few signs that Europeans were prepared to comply ahead of an EU-AU summit in Brussels.

Nearly a year after the creation and approval of vaccines in Europe, heads of state of the African Union are still looking for a patent waiver - even for a limited period - in order to increase their own production capacity.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Some rich EU countries that are home to major pharmaceutical hubs continue to oppose the move, despite the widespread recognition by EU leaders of a universal right to health.

The African Union has tried to include the patent waiver in the joint conclusions of the summit. But EU countries are not prepared to accept such wording, instead supporting weak language in favour of the "health sovereignty" of Africa.

"The African Union reiterates its support for the TRIPS [Trade-Related Aspects of Intellectual Property Rights] waiver request and urges the European Union to engage constructively towards conclusion of a targeted and time limited waiver which is critical to a WTO response to the Covid-19 Pandemic," the African Union proposed to say in the joint declaration, according to internal EU documents seen by EUobserver.

But the EU has suggested saying instead: "The African Union and the European Union commit to engage constructively towards a comprehensive WTO response on trade and health, which includes commitments on improved transparency, restraint from export restrictions, trade facilitating measures as well as intellectual property."

"The word 'waiver' is problematic and it is something the EU is not prepared to accept," an EU diplomat, who spoke on condition of anonymity, told EUobserver.

The EU has argued the patent waiver will not deliver what several of its officials have called a "miracle" solution.

French trade minister Franck Riester, whose country holds the rotating EU presidency, said intellectual property rights are crucial to spur innovation and lead investments into research.

"We do not want to call into question a system of intellectual property that allows for innovation and that has made it possible, in particular, to have vaccines very quickly in the case of Covid-19," he told a news conference earlier this week.

Europe's current vaccination rates, however, stand in stark contrast with the situation in Africa.

While more than 70 percent of Europeans are fully-vaccinated, the figure for Africans is just 11 percent - and even that disguises some major country-by-country variations.

Charles Chinedu Okeahalam, a Nigerian economist and businessman, told EUobserver the summit is likely to be "very high on talk, pledges and promises, photoshoot opportunities and posturing for domestic and international audiences" but would fall short of delivering any significant compromise on vaccine access.

The EU-AU summit comes just a few days before the next round of negotiations on the patent waiver at the World Trade Organisation (WTO) and some fifteen months after South Africa and India first proposed to lift intellectual property rights of Covid-19 vaccines and medicines.

WTO director-general Ngozi Okonjo-Iweala has been in talks with the EU, the US, India, and South Africa for two months seeking to bridge differences.

Those talks have been held in an "extremely difficult atmosphere," according to a source close to the negotiations, who declined to speak on the record.

Civil society organisations, meanwhile, have slammed US pharmaceutical giant Moderna for filing patent applications related to vaccine production in South Africa – a move that could potentially undermine plans to build African vaccine production.

The news comes after the South African company Afrigen announced it had reverse-engineered Moderna's vaccines.

Moderna did not answer EUobserver's request for comments.


If EU blocks vaccine waivers, it can drop 'solidarity' talk

Workers such as United Nurses Association of India are furious that the EU is undermining their best efforts and exacerbating the crisis by continuing to put big-pharma profits ahead of Covid vaccine patent-waivers. Is this what solidarity looks like?

Pressure builds on EU to back WTO vaccine-patent waiver

MEPs have backed a motion demanding the temporality lifting of intellectual properties rights of Covid-19 vaccines - a symbolic move that puts pressure on the European Commission to change its position on the issue of global access to vaccines.

Ramaphosa slams EU for protecting vaccine profits

African leaders, after their two-day summit in Brussels, called an offer by the EU to help Africa build vaccine-manufacturing plants was incomplete without backing a vaccine patent-waiver proposal.


Never waste a crisis - so start building Covid research in Africa

Botswana was the first country able to detect the emergence of the Omicron variant, thanks to its sequencing capacities. Eleven infectious disease experts from Africa and Europe call for developing research networks across the African continent to respond future pandemics.

EU’s €500m gender violence plan falls short, say auditors

The 'Spotlight Initiative' was launched in 2017 with a budget of €500 million to end all forms of violence or harmful practices against women and girls in partner countries, but so far it has had "little impact", say EU auditors.

Latest News

  1. Europe's energy strategy: A tale of competing priorities
  2. Why Greek state workers are protesting new labour law
  3. Gloves off, as Polish ruling party fights for power
  4. Here's the headline of every op-ed imploring something to stop
  5. Report: Tax richest 0.5%, raise €213bn for EU coffers
  6. EU aid for Africa risks violating spending rules, Oxfam says
  7. Activists push €40bn fossil subsidies into Dutch-election spotlight
  8. Europe must Trump-proof its Ukraine arms supplies

Stakeholders' Highlights

  1. International Medical Devices Regulators Forum (IMDRF)Join regulators, industry & healthcare experts at the 24th IMDRF session, September 25-26, Berlin. Register by 20 Sept to join in person or online.
  2. UNOPSUNOPS begins works under EU-funded project to repair schools in Ukraine
  3. Georgia Ministry of Foreign AffairsGeorgia effectively prevents sanctions evasion against Russia – confirm EU, UK, USA
  4. International Medical Devices Regulators Forum (IMDRF)Join regulators & industry experts at the 24th IMDRF session- Berlin September 25-26. Register early for discounted hotel rates
  5. Nordic Council of MinistersGlobal interest in the new Nordic Nutrition Recommendations – here are the speakers for the launch
  6. Nordic Council of Ministers20 June: Launch of the new Nordic Nutrition Recommendations

Stakeholders' Highlights

  1. International Sustainable Finance CentreJoin CEE Sustainable Finance Summit, 15 – 19 May 2023, high-level event for finance & business
  2. ICLEISeven actionable measures to make food procurement in Europe more sustainable
  3. World BankWorld Bank Report Highlights Role of Human Development for a Successful Green Transition in Europe
  4. Nordic Council of MinistersNordic summit to step up the fight against food loss and waste
  5. Nordic Council of MinistersThink-tank: Strengthen co-operation around tech giants’ influence in the Nordics
  6. EFBWWEFBWW calls for the EC to stop exploitation in subcontracting chains

Join EUobserver

Support quality EU news

Join us